RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$98.04
-1.23 (-1.24%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-0.67%
YTD
-6.64%
Open$99.61
Previous Close$99.27
Day High$100.03
Day Low$96.47
52W High$122.20
52W Low$74.50
Volume—
Avg Volume597.2K
Market Cap6.82B
P/E Ratio—
EPS$-3.05
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$105.86
Below
SMA 200
$92.90
Above
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+3.1% upside
Current
$98.04
$98.04
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 203.74M | 975.71M | 873.25M |
| Net Income | -211,028,071 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -204,734,350 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |